Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [31] Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
    Sanomachi, Tomomi
    Okuma, Hitomi Sumiyoshi
    Kitadai, Rui
    Kawachi, Asuka
    Yazaki, Shu
    Tokura, Momoko
    Arakaki, Motoko
    Saito, Ayumi
    Kita, Shosuke
    Yamamoto, Kasumi
    Maejima, Aiko
    Kojima, Yuki
    Nishikawa, Tadaaki
    Sudo, Kazuki
    Shimoi, Tatsunori
    Noguchi, Emi
    Fujiwara, Yasuhiro
    Sugino, Hirokazu
    Shiino, Sho
    Suto, Akihiko
    Yoshida, Masayuki
    Yonemori, Kan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer
    Thangavelu, Pulari U.
    Lin, Cheng-Yu
    Vaidyanathan, Srividya
    Nguyen, Thu H. M.
    Dray, Eloise
    Duijf, Pascal H. G.
    ONCOTARGET, 2017, 8 (37): : 62167 - 62182
  • [33] EndoPredict(R) in early hormone receptor-positive, HER2-negative breast cancer
    Almstedt, K.
    Mendoza, S.
    Otto, M.
    Battista, M. J.
    Steetskamp, J.
    Heimes, A. S.
    Krajnak, S.
    Poplawski, A.
    Gerhold-Ay, A.
    Hasenburg, A.
    Denkert, C.
    Schmidt, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 137 - 146
  • [34] Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer
    Bae, Soo Youn
    Kim, Sangmin
    Lee, Jun Ho
    Lee, Hyun-chul
    Lee, Se Kyung
    Kil, Won Ho
    Kim, Seok Won
    Lee, Jeong Eon
    Nam, Seok Jin
    BMC CANCER, 2015, 15
  • [35] High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer
    Liang, Rong
    Lin, Yan
    Yuan, Chun-Ling
    Liu, Zhi-Hui
    Li, Yong-Qiang
    Luo, Xiao-Ling
    Ye, Jia-Zhou
    Ye, Hai-Hong
    ONCOLOGY LETTERS, 2018, 15 (04) : 5933 - 5939
  • [36] Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancer
    Baglia, Michelle L.
    Cook, Linda S.
    Mei-Tzu, C.
    Wiggins, Charles
    Hill, Deirdre
    Porter, Peggy
    Li, Christopher I.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (08) : 1849 - 1857
  • [37] Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
    Niemeier, Leo A.
    Dabbs, David J.
    Beriwal, Sushil
    Striebel, Joan M.
    Bhargava, Rohit
    MODERN PATHOLOGY, 2010, 23 (02) : 205 - 212
  • [38] High expression levels of RUNX2 and HER2 indicate a poor prognosis in breast cancer tissues with calcification
    Liu, Xuemin
    Zhang, Yunsuo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (10): : 7873 - 7880
  • [39] Calmodulin 2 expression is associated with poor prognosis in breast cancer
    Yang, Ju
    Li, Shuixian
    Wang, Jigang
    Liu, Guoyuan
    Zhang, Chenyang
    Li, Xiaojing
    Liu, Xiuping
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 258
  • [40] Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer
    Seitz, K.
    Goossens, C.
    Huebner, H.
    Gass, P.
    Uhrig, S.
    Heindl, F.
    Emons, J.
    Ruebner, M.
    Anetsberger, D.
    Hartmann, A.
    Beckmann, M. W.
    Erber, R.
    Hack, C. C.
    Fasching, P. A.
    Haeberle, L.
    ESMO OPEN, 2024, 9 (11)
12345